Drug-labels.com

Dexmedetomidine Hydrochloride for Injection, USP (Baxter): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
100 mcg
Similar drugs:

Patient Medication Information: uses, side effects, how to take - Dexmedetomidine Hydrochloride for Injection, USP (Baxter)

What is Dexmedetomidine Hydrochloride for Injection, USP used for?

Dexmedetomidine Hydrochloride for Injection, USP is used in adults to keep you calm (sedated):

  • when you arrive at the intensive care unit (ICU) and have a breathing tube after you have had surgery under a general anesthesia
  • when you are having certain surgical procedures under a local anesthesia or nerve block
  • when you receive a breathing tube while you are awake

How does Dexmedetomidine Hydrochloride for Injection, USP work?

Dexmedetomidine Hydrochloride for Injection, USP works by activating a part of the brain which helps keep you calm.

What are the ingredients in Dexmedetomidine Hydrochloride for Injection, USP?

Medicinal ingredients: dexmedetomidine hydrochloride

Non-medicinal ingredients: sodium chloride and water for injection. Dexmedetomidine Hydrochloride for Injection, USP is preservative-free and contains no additives or other chemicals.

Dexmedetomidine Hydrochloride for Injection, USP comes in the following dosage forms:

Solution: 100 mcg / mL

Do not use Dexmedetomidine Hydrochloride for Injection, USP if:

  • you are allergic to dexmedetomidine hydrochloride or to any non-medicinal ingredient in Dexmedetomidine Hydrochloride for Injection, USP (see What are the ingredients in Dexmedetomidine Hydrochloride for Injection, USP?).

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Dexmedetomidine Hydrochloride for Injection, USP. Talk about any health conditions or problems you may have, including if you:

  • have heart problems, including chronic high blood pressure
  • have diabetes mellitus
  • have liver problems
  • have severe kidney problems
  • are taking any other medicines
  • have had a condition called malignant hyperthermia (a very high body temperature) after receiving Dexmedetomidine Hydrochloride for Injection, USP or another similar medication to calm you in the ICU, during surgery or other medical procedure
  • are dehydrated or suffer from excessive vomiting, diarrhea, or sweating
  • are older than 65 years of age
  • are pregnant or think you might be pregnant

  • are breastfeeding

Other warnings you should know about:

An increased mortality risk has been seen for patients 65 years of age and younger being administered this medicine. This was especially in patients with a more severe disease condition, who were admitted to the intensive care unit for reasons other than after surgery. The healthcare professional will decide if this medicine is still suitable for you.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with Dexmedetomidine Hydrochloride for Injection, USP:

  • anesthetic drugs, used during surgery such as: sevoflurane, isoflurane, propofol, alfentanil, and midazolam
  • neuromuscular blockers, used to relax you if you need a breathing tube such as rocuronium, cisatracurium
  • heart medications

How to take Dexmedetomidine Hydrochloride for Injection, USP:

  • Dexmedetomidine Hydrochloride for Injection, USP will be given to you by a healthcare professional skilled in the management of patients in the ICU or operating room setting.
  • Your healthcare professional will monitor your blood pressure, heart rate and oxygen levels while you are receiving Dexmedetomidine Hydrochloride for Injection, USP, and for as long as required, after you have stopped receiving Dexmedetomidine Hydrochloride for Injection, USP.
  • After you have received Dexmedetomidine Hydrochloride for Injection, USP it is important that you do not try to change position or get out of bed without assistance.

Usual dose:

Your healthcare professional will decide what the appropriate dose is for your specific case. You will get a starting dose first, then regular doses, specific for your body weight and the procedure you are undergoing. Your healthcare professional will decide what the appropriate dose is for your specific case.

Overdose:

If you think you, or a person you are caring for, have taken too much Dexmedetomidine Hydrochloride for Injection, USP, contact a healthcare professional, hospital emergency department, or regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

What are possible side effects from using Dexmedetomidine Hydrochloride for Injection,

USP?

These are not all the possible side effects you may have when taking Dexmedetomidine Hydrochloride for Injection, USP. If you experience any side effects not listed here, tell your healthcare professional.

Tell your healthcare professional if you have any of the following side effects within 48 hours after receiving Dexmedetomidine Hydrochloride for Injection, USP:

  • dry mouth
  • nausea, vomiting
  • diarrhea
  • constipation
  • nervousness, agitation
  • headaches
  • weakness
  • confusion
  • excessive sweating
  • weight loss
  • salt cravings
  • dizziness or light-headedness
  • low blood pressure
  • slower than normal heart beat

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
COMMON
Hypotension (low blood pressure): dizziness, fainting, light-headedness✓
Hypertension (high blood pressure): headaches, vision disorders, nausea and vomiting✓
Hyperglycemia (high blood sugar): frequent urination, thirst, hunger✓
Hypokalemia (low potassium blood level): irregular heartbeats, muscle weakness and generally feeling unwell✓
Bradycardia: slow heartbeat✓
Tachycardia: fast heartbeat✓
Hypoxia: blueish colouration to the skin, confusion, fast heartbeat, shortness of breath, sweating✓
RARE
Anaemia (low levels of red blood cells): fatigue, loss of energy, weakness, shortness of breath✓
Breathing problems✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting)for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.
NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Dexmedetomidine Hydrochloride for Injection, USP is stored between 15°C to 30°C.

Keep out of reach and sight of children.

If you want more information about Dexmedetomidine Hydrochloride for Injection, USP:

  • Talk to your healthcare professional.
  • Find the full Product Monograph that is prepared for healthcare professionals and includes the Patient Medication Information by visiting the Health Canada Drug Product Database website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website www.baxter.ca; or by calling 1-888-719-9955.

Last revised: APR 14, 2025

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02513978

Revision date stated in the text: April 14, 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Dexmedetomidine Hydrochloride for Injection, USP (Baxter)

Rx or OTC
Prescription (Rx)?
DIN 02513978
Schedule(s) PRESCRIPTION
Active ingredient(s) Dexmedetomidine (dexmedetomidine hydrochloride) 100 MCG
Dosage form(s) Solution
Route(s) of administration Intravenous
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N05 Psycholeptics
      1. N05C Hypnotics and sedatives
        1. N05CM Other hypnotics and sedatives
          1. N05CM18 Dexmedetomidine
Company BAXTER CORPORATION
Current status Marketed
Current status date June 5, 2024

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.